Fig. 3From: Biopharma innovation trends during COVID-19 and beyond: an evidence from global partnerships and fundraising activities, 2011-2022Trends in the 32 categories of fundraising deals by therapy area, molecule type, and development phase. Figure 3 presents the cumulative amount raised in each category since January 2011Back to article page